| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |